| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.853 | 0.004 | 0.853 | Aldehyde oxidase inhibitor | 0.62 0.016 DBMET02624 | ||
| 0.544 | 0.003 | 0.544 | Antibacterial (Helicobacter pylori) | 0.362 0.005 DBMET02624 | ||
| 0.535 | 0.032 | 0.535 | Antibacterial | 0.515 0.036 DBMET02624 | ||
| 0.403 | 0.007 | 0.42 | Alkylator | 0.42 0.007 DBMET02624 | DBMET02624 | |
| 0.371 | 0.004 | 0.371 | Alcohol dehydrogenase inhibitor | 0.206 0.012 DBMET02624 | ||
| 0.389 | 0.023 | 0.399 | DNA synthesis inhibitor | 0.399 0.022 DBMET02624 | DBMET02624 | |
| 0.354 | 0.005 | 0.354 | Beta glucuronidase inhibitor | 0.19 0.014 DBMET02624 | ||
| 0.349 | 0.008 | 0.358 | Cell wall synthesis inhibitor | 0.358 0.008 DBMET02624 | DBMET02624 | |
| 0.304 | 0.005 | 0.304 | Urease inhibitor | 0.161 0.018 DBMET02624 | ||
| 0.379 | 0.086 | 0.379 | Histamine release inhibitor | 0.29 0.129 DBMET02624 | ||
| 0.366 | 0.077 | 0.366 | GABA C receptor rho-3 antagonist | 0.227 0.177 DBMET02624 | ||
| 0.269 | 0.014 | 0.269 | DNA intercalator | 0.211 0.023 DBMET02624 | ||
| 0.224 | 0.004 | 0.224 | Thioredoxin reductase inhibitor | 0.206 0.004 DBMET02624 | ||
| 0.269 | 0.055 | 0.269 | Cyclic AMP phosphodiesterase inhibitor | 0.156 0.143 DBMET02624 | ||
| 0.214 | 0.004 | 0.214 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.135 0.009 DBMET02624 | ||
| 0.27 | 0.065 | 0.27 | Interleukin agonist | 0.216 0.106 DBMET02624 | ||
| 0.34 | 0.153 | 0.367 | Caspase 9 stimulant | 0.367 0.132 DBMET02624 | DBMET02624 | |
| 0.2 | 0.03 | 0.2 | Mannose-6-phosphate isomerase inhibitor | 0.14 0.074 DBMET02624 | ||
| 0.279 | 0.114 | 0.279 | Calcium channel activator | 0.272 0.122 DBMET02624 | ||
| 0.18 | 0.017 | 0.18 | Epidermal growth factor antagonist | 0.178 0.018 DBMET02624 | ||
| 0.181 | 0.019 | 0.181 | Interleukin 8 antagonist | 0.119 0.062 DBMET02624 | ||
| 0.332 | 0.171 | 0.332 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.271 0.255 DBMET02624 | ||
| 0.174 | 0.013 | 0.199 | ErbB-2 antagonist | 0.199 0.009 DBMET02624 | DBMET02624 | |
| 0.262 | 0.106 | 0.318 | Interleukin 2 agonist | 0.318 0.062 DBMET02624 | DBMET02624 | |
| 0.174 | 0.022 | 0.234 | UDP-glucose 4-epimerase inhibitor | 0.234 0.014 DBMET02624 | DBMET02624 | |
| 0.267 | 0.115 | 0.267 | Vasodilator, peripheral | |||
| 0.2 | 0.049 | 0.2 | Succinate dehydrogenase inhibitor | 0.183 0.065 DBMET02624 | ||
| 0.156 | 0.013 | 0.156 | HIV-1 reverse transcriptase inhibitor | 0.119 0.022 DBMET02624 | ||
| 0.152 | 0.01 | 0.154 | Lanosterol 14 alpha demethylase inhibitor | 0.154 0.01 DBMET02624 | DBMET02624 | |
| 0.18 | 0.041 | 0.238 | Alpha-N-acetylglucosaminidase inhibitor | 0.238 0.025 DBMET02624 | DBMET02624 | |
| 0.173 | 0.036 | 0.177 | Epidermal growth factor receptor kinase inhibitor | 0.177 0.034 DBMET02624 | DBMET02624 | |
| 0.297 | 0.16 | 0.395 | Calcium channel L-type activator | 0.395 0.085 DBMET02624 | DBMET02624 | |
| 0.142 | 0.022 | 0.175 | Triose-phosphate isomerase inhibitor | 0.175 0.014 DBMET02624 | DBMET02624 | |
| 0.132 | 0.014 | 0.148 | Carbamoyl phosphate synthetase inhibitor | 0.148 0.011 DBMET02624 | DBMET02624 | |
| 0.146 | 0.028 | 0.15 | Adenylate kinase inhibitor | 0.15 0.026 DBMET02624 | DBMET02624 | |
| 0.171 | 0.055 | 0.171 | Amylase inhibitor | 0.109 0.089 DBMET02624 | ||
| 0.248 | 0.136 | 0.248 | Vasodilator, coronary | 0.223 0.161 DBMET02624 | ||
| 0.2 | 0.088 | 0.206 | Nitric-oxide synthase stimulant | 0.206 0.078 DBMET02624 | DBMET02624 | |
| 0.203 | 0.095 | 0.203 | Peptidyltransferase inhibitor | 0.17 0.146 DBMET02624 | ||
| 0.176 | 0.068 | 0.176 | Antipruritic | |||
| 0.118 | 0.014 | 0.118 | Alcohol oxidase inhibitor | 0.091 0.02 DBMET02624 | ||
| 0.119 | 0.017 | 0.119 | Interferon agonist | 0.111 0.021 DBMET02624 | ||
| 0.145 | 0.051 | 0.145 | Aldehyde dehydrogenase inhibitor | 0.128 0.063 DBMET02624 | ||
| 0.205 | 0.112 | 0.205 | Superoxide dismutase inhibitor | 0.175 0.149 DBMET02624 | ||
| 0.103 | 0.011 | 0.103 | Interferon inducer | 0.096 0.014 DBMET02624 | ||
| 0.125 | 0.037 | 0.125 | Creatine kinase inhibitor | 0.104 0.055 DBMET02624 | ||
| 0.092 | 0.005 | 0.092 | Thymidylate synthase inhibitor | 0.08 0.007 DBMET02624 | ||
| 0.125 | 0.039 | 0.125 | DOPA decarboxylase inhibitor | 0.123 0.041 DBMET02624 | ||
| 0.103 | 0.018 | 0.103 | Biliverdin reductase inhibitor | 0.094 0.02 DBMET02624 | ||
| 0.181 | 0.097 | 0.181 | Neurotrophic factor enhancer | 0.166 0.115 DBMET02624 | ||
| 0.127 | 0.044 | 0.127 | Xanthine oxidase inhibitor | 0.101 0.059 DBMET02624 | ||
| 0.113 | 0.031 | 0.123 | Porphobilinogen synthase inhibitor | 0.123 0.027 DBMET02624 | DBMET02624 | |
| 0.118 | 0.037 | 0.118 | MAP kinase kinase 1 inhibitor | |||
| 0.197 | 0.118 | 0.361 | DNA damaging | 0.361 0.038 DBMET02624 | DBMET02624 | |
| 0.111 | 0.033 | 0.111 | Carbonic anhydrase VI inhibitor | 0.094 0.043 DBMET02624 | ||
| 0.191 | 0.114 | 0.251 | RNA-directed DNA polymerase inhibitor | 0.251 0.049 DBMET02624 | DBMET02624 | |
| 0.142 | 0.066 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.136 0.088 DBMET02624 | ||
| 0.131 | 0.057 | 0.131 | Beta amyloid protein antagonist | |||
| 0.149 | 0.076 | 0.149 | Cytidine deaminase inhibitor | |||
| 0.101 | 0.031 | 0.134 | Phosphofructokinase-1 inhibitor | 0.134 0.021 DBMET02624 | DBMET02624 | |
| 0.082 | 0.018 | 0.082 | Phosphodiesterase 1C inhibitor | |||
| 0.103 | 0.041 | 0.127 | NADH dehydrogenase inhibitor | 0.127 0.025 DBMET02624 | DBMET02624 | |
| 0.107 | 0.049 | 0.107 | Phosphodiesterase 7B inhibitor | |||
| 0.135 | 0.08 | 0.135 | Growth factor antagonist | 0.11 0.103 DBMET02624 | ||
| 0.069 | 0.018 | 0.088 | Alpha-mannosidase inhibitor | 0.088 0.009 DBMET02624 | DBMET02624 | |
| 0.072 | 0.024 | 0.096 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.096 0.015 DBMET02624 | DBMET02624 | |
| 0.073 | 0.026 | 0.073 | Carbonic anhydrase VB inhibitor | 0.063 0.033 DBMET02624 | ||
| 0.138 | 0.092 | 0.138 | GABA C receptor rho-2 antagonist | |||
| 0.074 | 0.029 | 0.074 | Nitric oxide donor | 0.069 0.034 DBMET02624 | ||
| 0.086 | 0.042 | 0.086 | Focal adhesion kinase 1 inhibitor | 0.073 0.057 DBMET02624 | ||
| 0.137 | 0.094 | 0.137 | MAP kinase kinase 4 inhibitor | |||
| 0.079 | 0.037 | 0.079 | Sphingosine 1-phosphate receptor 4 agonist | 0.073 0.042 DBMET02624 | ||
| 0.253 | 0.211 | 0.253 | Apoptosis agonist | |||
| 0.201 | 0.161 | 0.201 | Thyroid hormone antagonist | 0.191 0.17 DBMET02624 | ||
| 0.058 | 0.018 | 0.081 | Mannosidase inhibitor | 0.081 0.009 DBMET02624 | DBMET02624 | |
| 0.097 | 0.058 | 0.097 | Phosphodiesterase 6D inhibitor | |||
| 0.069 | 0.031 | 0.069 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.131 | 0.093 | 0.149 | MAP3K9 inhibitor | 0.149 0.061 DBMET02624 | DBMET02624 | |
| 0.17 | 0.135 | 0.17 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.193 | 0.16 | 0.193 | Thyroid hormone beta antagonist | 0.183 0.171 DBMET02624 | ||
| 0.074 | 0.041 | 0.074 | Carbonic anhydrase VA inhibitor | 0.069 0.048 DBMET02624 | ||
| 0.108 | 0.076 | 0.108 | Microtubule formation inhibitor | |||
| 0.214 | 0.183 | 0.294 | Immunosuppressant | 0.294 0.119 DBMET02624 | DBMET02624 | |
| 0.253 | 0.224 | 0.253 | 5 Hydroxytryptamine release inhibitor | |||
| 0.092 | 0.063 | 0.111 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.111 0.045 DBMET02624 | DBMET02624 | |
| 0.039 | 0.013 | 0.048 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.048 0.009 DBMET02624 | DBMET02624 | |
| 0.056 | 0.034 | 0.06 | Ornithine carbamoyltransferase inhibitor | 0.06 0.031 DBMET02624 | DBMET02624 | |
| 0.045 | 0.023 | 0.049 | Thymidine kinase inhibitor | 0.049 0.019 DBMET02624 | DBMET02624 | |
| 0.086 | 0.064 | 0.086 | Phosphodiesterase I inhibitor | |||
| 0.065 | 0.047 | 0.065 | Carbonic anhydrase V inhibitor | 0.061 0.052 DBMET02624 | ||
| 0.082 | 0.064 | 0.082 | mTOR complex 2 inhibitor | |||
| 0.03 | 0.012 | 0.035 | Thymidine phosphorylase inhibitor | 0.035 0.008 DBMET02624 | DBMET02624 | |
| 0.202 | 0.185 | 0.202 | Sodium/bile acid cotransporter inhibitor | |||
| 0.057 | 0.041 | 0.057 | Glutamate (mGluR1) antagonist | |||
| 0.112 | 0.097 | 0.126 | Interleukin 4 antagonist | 0.126 0.077 DBMET02624 | DBMET02624 | |
| 0.07 | 0.056 | 0.072 | Glutamate dehydrogenase inhibitor | 0.072 0.054 DBMET02624 | DBMET02624 | |
| 0.048 | 0.035 | 0.053 | Cytokine production stimulant | 0.053 0.022 DBMET02624 | DBMET02624 | |
| 0.088 | 0.076 | 0.088 | Interleukin 12 antagonist | |||
| 0.066 | 0.055 | 0.1 | Histidine decarboxylase inhibitor | 0.1 0.032 DBMET02624 | DBMET02624 | |
| 0.022 | 0.011 | 0.022 | Toll-Like receptor 8 agonist | 0.022 0.01 DBMET02624 | ||
| 0.058 | 0.047 | 0.058 | Phosphodiesterase 1A inhibitor | |||
| 0.07 | 0.06 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.056 | 0.048 | 0.056 | Phosphodiesterase 1B inhibitor | |||
| 0.043 | 0.037 | 0.052 | Adenosine deaminase inhibitor | 0.052 0.028 DBMET02624 | DBMET02624 | |
| 0.041 | 0.036 | 0.041 | Geranyltranstransferase inhibitor | |||
| 0.044 | 0.04 | 0.054 | Glucose-6-phosphate isomerase inhibitor | 0.054 0.024 DBMET02624 | DBMET02624 | |
| 0.025 | 0.022 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 DBMET02624 | DBMET02624 | |
| 0.069 | 0.066 | 0.069 | Phosphodiesterase VI inhibitor | |||
| 0.081 | 0.08 | 0.081 | Aminopeptidase B inhibitor | |||
| 0.029 | 0.028 | 0.029 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.086 | 0.085 | 0.086 | GABA C receptor agonist | 0.086 0.085 DBMET02624 | ||
| 0.046 | 0.048 | 0.049 | Acyl-CoA dehydrogenase inhibitor | 0.049 0.044 DBMET02624 | DBMET02624 | |
| 0.036 | 0.044 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.032 DBMET02624 | DBMET02624 | |
| 0.019 | 0.032 | 0.028 | Uridine phosphorylase inhibitor | 0.028 0.02 DBMET02624 | DBMET02624 | |
| 0.065 | 0.107 | 0.081 | HIV-1 integrase (Overall Integration) inhibitor | 0.081 0.077 DBMET02624 | DBMET02624 | |
| 0.073 | 0.137 | 0.092 | Toll-Like receptor 4 antagonist | 0.092 0.085 DBMET02624 | DBMET02624 | |
| 0.075 | 0.176 | 0.157 | Toll-Like receptor antagonist | 0.157 0.051 DBMET02624 | DBMET02624 | |
| 0.025 | 0.15 | 0.076 | Peroxisome proliferator-activated receptor gamma agonist | 0.076 0.043 DBMET02624 | DBMET02624 | |
| 0.089 | 0.316 | 0.234 | Hypoglycemic | 0.234 0.087 DBMET02624 | DBMET02624 | |
| 0.139 | 0.439 | 0.397 | Antiinflammatory | 0.397 0.141 DBMET02624 | DBMET02624 | |
| 0.065 | 0.5 | 0.409 | Immunomodulator | 0.409 0.041 DBMET02624 | DBMET02624 | |
| 0.018 | 0.673 | 0.142 | Insulin secretagoues | 0.142 0.082 DBMET02624 | DBMET02624 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |